Table 4.

Baseline characteristics of the total cohort and PSM cohort.

	Total cohort			PSM 1:3
	Non- ERAS	ERAS	p	Non- ERAS	ERAS	p
Parameter
Total n	90	959		87	258
Female	37 (41.1)	436 (45.5)	0.363	36 (41.4)	107 (41.5)	0.988
Age (years)	63.4 ± 13.8	61.5 ± 13.2	0.204	63.1 ± 13.9	62.7 ± 13.1	0.799
Preoperative weight (kg)	75.5 ± 15.6	77.3 ± 17.1	0.339	75.6 ± 15.7	77.6 ± 17.9	0.365
Height (cm)	171.2 ± 8.8	172.2 ± 9.3	0.322	171.4 ± 8.6	172.2 ± 9.2	0.479
Serum bilirubin total (mg/dl)	0.67 ± 1.1	0.47 ± 0.59	0.004	0.68 ± 1.1	0.56 ± 0.76	0.295
Hemoglobin (g/dl)	13.2 ± 1.7	13.2 ± 1.7	0.738	13.2 ± 1.7	13.1 ± 1.8	0.668
White blood cell count	7.4 ± 3.6	7.2 ± 2.6	0.574	7.4 ± 3.7	7.5 ± 2.5	0.852
Diabetes mellitus	20 (23)	157 (16.4)	0.184	19 (21.8)	61 (23.6)	0.771
Neoadjuvant chemotherapie	26 (29.9)	352 (36.7)	0.317	26 (29.9)	93 (36)	0.296
Neoadjuvant radiotherapy to operating field	2 (2.3)	23 (2.4)	0.907	2 (2.3)	11 (4.3)	0.529
LOS (night at hospital after primary operation)	10.3 ± 8.6	10.3 ± 14.9	0.993	10.2 ± 8.7	10.4 ± 12.3	0.900

The data are presented as mean ± SD or n (%).

Siginficance value is bold.